Chongqing Daxin Pharmaceutical Co., Ltd. is the world's largest manufacturing base for Lovastatin, operating advanced pharmaceutical facilities in Shuitu, Liangjiang New District, Chongqing, including a new site built to international GMP standards. The company manufactures around a hundred active pharmaceutical ingredients, finished dosage forms, and intermediates spanning cardiovascular drugs, antibiotics, immunosuppressants, and plasma volume expanders, and offers CMO, CSO, and CDMO contract services on an OEM basis. Selling to North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa under FOB, CIF, EXW, CIP, and CPT delivery terms, Daxin is valued for its international certifications, experienced R&D personnel, rich product line, and high-quality, buyer-responsive service.
No comments available.
Leave your rating & comment